Región del Maule
Este organismo compró $227.954.985 en 174 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos para el sistema nervioso central / Antidepresivos y le compró principalmente a Scm Pharma SpA.
14 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 1428666-57-AG25 | 04-04-2025 | Tecnofarma S.A. | Recepcion Conforme | $687.582 |
| 1428666-56-AG25 | 03-04-2025 | Novo Nordisk Farmaceutica Limitada | Recepcion Conforme | $6.721.120 |
| 1428666-48-AG25 | 01-04-2025 | Ethon Pharmaceuticals Ltda. | Recepcion Conforme | $3.397.688 |
| 1428666-49-AG25 | 01-04-2025 | Laboratorio Chile S.A. | Recepcion Conforme | $476.238 |
| 1428666-50-AG25 | 01-04-2025 | Opko Chile S.A. | Recepcion Conforme | $1.181.670 |
| 1428666-51-AG25 |
| $8,7 M |
| 2025 | $219,3 M |
14 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| 01-04-2025 |
| Inversiones Sb S.A. |
| Recepcion Conforme |
| $334.628 |
| 1428666-52-AG25 | 01-04-2025 | Ethon Pharmaceuticals Ltda. | Recepcion Conforme | $2.694.636 |
| 1428666-55-AG25 | 01-04-2025 | Becrux Labs SpA | Recepcion Conforme | $388.416 |
| 1428666-47-AG25 | 28-03-2025 | Sociedad Comercializadora Medikar Limitada | Recepcion Conforme | $540.855 |
| 1428666-41-TD25 | 26-03-2025 | Segury Comercial SpA | Recepcion Conforme | $785.400 |
| 1428666-42-AG25 | 26-03-2025 | Drogueria Global Pharma SpA | Recepcion Conforme | $5.596.570 |
| 1428666-43-AG25 | 26-03-2025 | Thea Pharma SpA | Recepcion Conforme | $1.249.679 |
| 1428666-44-AG25 | 26-03-2025 | Megalabs Chile S.A. | Recepcion Conforme | $680.680 |
| 1428666-45-AG25 | 26-03-2025 | Comercial Gava Limitada | Recepcion Conforme | $921.060 |
| 1428666-46-AG25 | 26-03-2025 | Opko Chile S.A. | Recepcion Conforme | $1.426.215 |
| 1428666-35-AG25 | 20-03-2025 | Farmaceutica Caribean SpA | Recepcion Conforme | $1.742.160 |
| 1428666-36-AG25 | 20-03-2025 | Laboratorios Andromaco S.A. | Recepcion Conforme | $1.517.250 |
| 1428666-37-AG25 | 20-03-2025 | Novofarma Service S.A. | Recepcion Conforme | $1.283.058 |
| 1428666-38-AG25 | 20-03-2025 | Novofarma Service S.A. | Recepcion Conforme | $1.445.850 |
| 1428666-39-AG25 | 20-03-2025 | Laboratorios Andromaco S.A. | Recepcion Conforme | $1.993.488 |
| 1428666-40-AG25 | 20-03-2025 | Inversiones Sb S.A. | Recepcion Conforme | $1.435.854 |
| 1428666-31-AG25 | 18-03-2025 | Laboratorio Chile S.A. | Recepcion Conforme | $1.018.640 |
| 1428666-32-AG25 | 18-03-2025 | Laboratorios Andromaco S.A. | Recepcion Conforme | $3.300.584 |
| 1428666-33-AG25 | 18-03-2025 | Laboratorios Andromaco S.A. | Recepcion Conforme | $883.575 |
| 1428666-34-AG25 | 18-03-2025 | Scm Pharma SpA | Recepcion Conforme | $1.675.639 |
| 1428666-28-AG25 | 17-03-2025 | Megalabs Chile S.A. | Recepcion Conforme | $753.270 |
| 1428666-29-AG25 | 17-03-2025 | Laboratorio Chile S.A. | Recepcion Conforme | $3.466.470 |
| 1428666-30-AG25 | 17-03-2025 | Emcure Pharma Chile SpA | Recepcion Conforme | $971.040 |
| 1428666-27-AG25 | 14-03-2025 | Scm Pharma SpA | Recepcion Conforme | $1.800.589 |
| 1428666-23-AG25 | 12-03-2025 | Laboratorio Chile S.A. | Recepcion Conforme | $668.780 |
